ECM
COCH icon

ExodusPoint Capital Management’s Envoy Medical COCH Stock Holding History

ExodusPoint Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+182,354
New +$124K ﹤0.01% 1447

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ExodusPoint Capital Management's COCH Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Envoy Medical (COCH) in Q2 2026: 182,354 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1447 among its holdings.

33 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • ExodusPoint Capital Management held 182,354 shares of Envoy Medical worth $144K as of Q2 2026.
  • Envoy Medical was a new ExodusPoint Capital Management position in Q2 2026.
  • Envoy Medical made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1447 holding.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.